시장보고서
상품코드
1825860

세계의 경피적 신쇄석술 시장 보고서(2025년)

Percutaneous Nephrolithotomy Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

경피적 신쇄석술 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.2%로 266억 달러로 성장할 것입니다. 예측 기간의 성장은 최소침습 수술의 채택 확대, 효과적인 결석 제거 기술에 대한 수요 증가, 경피적 신쇄석술의 이점에 대한 인식 증가, 신장 결석에 취약한 노인 인구 증가, 결석 제거를 위한 첨단 의료 기술의 가용성 증가, 환자 중심 치료에 대한 관심 증가, 외래 수술에 대한 선호도 증가에 대한 선호도 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 소형화 기구의 채용, 영상 기술의 발전, 로봇 공학의 도입, 일회용 기구의 채용, 결석 제거 기구의 발전, 마취 기술의 발전, 감염 관리 대책의 강화, 멀티모달 통증 관리의 도입, 교육 프로그램의 개발 등을 들 수 있습니다.

향후 5년간 8.2%의 성장률 전망은 지난번 전망치보다 0.6% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 일본과 독일에서 수입되는 신장경과 결석파쇄장치의 비용을 상승시키고, 신장결석 제거 수술을 지연시키거나 수술 부문의 비용을 상승시킬 수 있기 때문에 미국 비뇨기과 센터에 도전이 될 수 있습니다. 이러한 영향은 또한 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 더 광범위하게 느껴질 것으로 보입니다.

신장 질환의 유병률 증가는 향후 몇 년간 경피적 신쇄석술 시장의 성장을 견인할 것으로 보입니다. 신장 질환에는 신장에 영향을 미치고 적절한 기능을 저해하는 다양한 병태가 포함됩니다. 신장 질환의 확산에 기여하는 요인으로는 당뇨병과 고혈압 비율의 증가, 고령화, 생활습관 선택, 유전적 요인, 만성질환, 인식 및 진단의 향상 등이 있습니다. 경피적 신결석 제거술은 큰 신장 결석이나 복잡한 신장 결석을 제거하고, 통증을 완화하고, 요로 감염을 예방하고, 신장 기능을 향상시키는 최소침습적 수술 방법을 제공함으로써 신장 질환 관리에 중요한 역할을 하고 있습니다. 예를 들어, 영국에 본사를 둔 신장 조사 위원회는 2023년 6월, 2023년 영국에서 신장 질환이 719만 명에게 영향을 미치고 2033년에는 761만 명으로 증가할 것으로 예상한다고 보고했습니다. 따라서 신장 질환의 유병률 증가는 경피적 신쇄석술 시장의 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 경피적 신쇄석술 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업 분석
  • 세계의 경피적 신쇄석술 시장 : 성장률 분석
  • 세계의 경피적 신쇄석술 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 경피적 신쇄석술 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 경피적 신쇄석술 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 경피적 신쇄석술 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 인산 마그네슘 암모늄 결석
  • 석회 질형
  • 요산 결석 종류
  • 세계의 경피적 신쇄석술 시장 : 구성요소별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 액세서리
  • 디바이스
  • 서비스
  • 세계의 경피적 신쇄석술 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 외래 수술 센터
  • 클리닉
  • 병원
  • 세계의 경피적 신쇄석술 시장 : 하위 세분화 인산 마그네슘 암모늄 결석 종류, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 스트루바이트 결석
  • 삼중 인산 돌
  • 세계의 경피적 신쇄석술 시장 : 하위 세분화 석회 질형, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 옥살산칼슘 결석
  • 인산칼슘 결석
  • 세계의 경피적 신쇄석술 시장 : 하위 세분화 요산 결석 종류, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 원발성 요산 결석
  • 이차성 요산 결석

제7장 지역별·국가별 분석

  • 세계의 경피적 신쇄석술 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 경피적 신쇄석술 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 경피적 신쇄석술 시장 : 경쟁 구도
  • 경피적 신쇄석술 시장 : 기업 개요
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Coloplast Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

  • B. Braun
  • Cook Medical
  • Teleflex Incorporated
  • Karl Storz Se And Co. KG
  • Merit Medical Systems
  • Richard Wolf GmbH
  • AngioDynamics
  • Argon Medical Devices
  • Dornier MedTech
  • EDAP TMS
  • Allengers Medical Systems Limited
  • DirexGroup
  • Envaste Limited
  • ELMED Lithotripsy Systems
  • PolyDiagnost

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

  • 경피적 신쇄석술 시장 2029 : 새로운 기회를 제공하는 국가
  • 경피적 신쇄석술 시장 2029 : 새로운 기회를 제공하는 부문
  • 경피적 신쇄석술 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁 전략

제36장 부록

KSM 25.10.13

Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable.

The main types of kidney stones treated by percutaneous nephrolithotomy include magnesium ammonium phosphate stones, calcareous stones, and uric acid calculi. Magnesium ammonium phosphate (MAP) stones are composed of magnesium, ammonium, and phosphate ions. The components involved in PCNL include accessories, devices, and services, which are utilized by end users such as ambulatory surgical centers, clinics, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The percutaneous nephrolithotomy market research report is one of a series of new reports from The Business Research Company that provides percutaneous nephrolithotomy market statistics, including the percutaneous nephrolithotomy industry global market size, regional shares, competitors with percutaneous nephrolithotomy market share, detailed percutaneous nephrolithotomy market segments, market trends, and opportunities, and any further data you may need to thrive in the percutaneous nephrolithotomy industry. These percutaneous nephrolithotomy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The percutaneous nephrolithotomy market size has grown strongly in recent years. It will grow from $17.9 billion in 2024 to $19.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of kidney stones, rising demand for effective and efficient treatment options for kidney stones, expansion of healthcare infrastructure in emerging economies, aging population leading to a higher incidence of kidney stones, surge in research and development activities, increasing healthcare expenditure, growing emphasis on patient-centric healthcare.

The percutaneous nephrolithotomy market size is expected to see strong growth in the next few years. It will grow to $26.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing adoption of minimally invasive surgical procedures, rising demand for effective stone removal techniques, increasing awareness about the benefits of percutaneous nephrolithotomy, growing geriatric population prone to kidney stone formation, growing availability of advanced medical technologies for stone removal, increasing focus on patient-centric care, increasing preference for outpatient procedures. Major trends in the forecast period include adoption of miniaturized instruments, advancement in imaging technologies, implementation of robotics, adoption of disposable devices, advancement in stone retrieval devices, advancement in anesthesia techniques, implementation of enhanced infection control measures, implementation of multimodal pain management, development of training programs.

The forecast of 8.2% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. urology centers by increasing costs for nephroscopes and lithotripsy devices imported from Japan and Germany, potentially delaying kidney stone removal procedures and raising surgical department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of renal diseases is set to drive the growth of the percutaneous nephrolithotomy market in the coming years. Renal diseases encompass a variety of conditions affecting the kidneys and hindering their proper functioning. Factors contributing to the prevalence of renal diseases include rising rates of diabetes and hypertension, an aging population, lifestyle choices, genetic factors, chronic conditions, and improved awareness and diagnosis. Percutaneous nephrolithotomy plays a crucial role in managing renal diseases by offering a minimally invasive surgical procedure to remove large or complex kidney stones, alleviate pain, prevent urinary tract infections, and enhance kidney function. For example, a UK-based Kidney Research Commission reported in June 2023 that kidney disease affected 7.19 million people in the UK in 2023 and is projected to increase to 7.61 million by 2033. Hence, the increasing prevalence of renal diseases is fueling growth in the percutaneous nephrolithotomy market.

Leading companies in the percutaneous nephrolithotomy market are concentrating on implementing innovative solutions, such as robot-assisted surgical platforms, to improve surgical precision and patient outcomes. A robot-assisted surgical platform is an advanced medical system utilizing robotic technology to aid surgeons in performing complex procedures with enhanced precision, control, and flexibility. For instance, Ethicon Inc., a US-based Johnson & Johnson MedTech company, announced in February 2023 the successful robotic-assisted removal of kidney stones in the first patient using the MONARCH Platform for urology. This platform enables urologists to navigate the kidney with robotic assistance, facilitating access, clearance, and control via a handheld controller. It offers a unified platform supporting ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, delivering enhanced navigation, access, clearance, and control compared to traditional methods.

The growing adoption of minimally invasive surgeries (MIS) is expected to drive the expansion of the percutaneous nephrolithotomy (PCNL) market. Invasive surgeries involve making incisions to enter the body for the treatment or diagnosis of medical conditions. The increasing preference for MIS is attributed to key benefits such as shorter recovery times, reduced hospital stays, lower risk of complications, less pain and scarring, and greater precision due to advanced technologies. These advantages make MIS particularly beneficial for percutaneous nephrolithotomy (PCNL), as it offers a less invasive method for treating kidney stones. For example, in January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, revealed that in 2022, approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems. This represented an 18% increase compared to the 1,594,000 procedures conducted in 2021. As a result, the rising adoption of minimally invasive surgeries is fueling the growth of the percutaneous nephrolithotomy market.

Major companies operating in the percutaneous nephrolithotomy market are Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Coloplast Corporation, B. Braun, Cook Medical, Teleflex Incorporated, Karl Storz Se And Co. KG, Merit Medical Systems, Richard Wolf GmbH, AngioDynamics, Argon Medical Devices, Dornier MedTech, EDAP TMS, Allengers Medical Systems Limited, DirexGroup, Envaste Limited, ELMED Lithotripsy Systems, PolyDiagnost, Attikouris Enterprises Ltd., Advin Urology, Avenda Health, Guangzhou Potent Optotronic Technology Co. Ltd., Surgimedik

North America was the largest region in the percutaneous nephrolithotomy market in 2024. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the percutaneous nephrolithotomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The percutaneous nephrolithotomy market consists of revenues earned by entities by providing services such as preoperative consultation and assessment, imaging services, anesthesia services, and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous nephrolithotomy market also includes sales of nephroscopes, lithotripters, and guidewires. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Percutaneous Nephrolithotomy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on percutaneous nephrolithotomy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for percutaneous nephrolithotomy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The percutaneous nephrolithotomy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Magnesium Ammonium Phosphate Stone Type; Calcareous Type; Uric Acid Calculi Type
  • 2) By Component: Accessories; Devices; Services
  • 3) By End-User: Ambulatory Surgical Centers; Clinics; Hospitals
  • Subsegments:
  • 1) By Magnesium Ammonium Phosphate Stone Type: Struvite Stones; Triple Phosphate Stones
  • 2) By Calcareous Type: Calcium Oxalate Stones; Calcium Phosphate Stones
  • 3) By Uric Acid Calculi Type: Primary Uric Acid Stones; Secondary Uric Acid Stones
  • Companies Mentioned: Boston Scientific Corporation; Zimmer Biomet Holdings Inc.; Olympus Corporation; Terumo Corporation; Coloplast Corporation; B. Braun; Cook Medical; Teleflex Incorporated; Karl Storz Se And Co. KG; Merit Medical Systems; Richard Wolf GmbH; AngioDynamics; Argon Medical Devices; Dornier MedTech; EDAP TMS; Allengers Medical Systems Limited; DirexGroup; Envaste Limited; ELMED Lithotripsy Systems; PolyDiagnost; Attikouris Enterprises Ltd.; Advin Urology; Avenda Health; Guangzhou Potent Optotronic Technology Co. Ltd.; Surgimedik
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Percutaneous Nephrolithotomy Market Characteristics

3. Percutaneous Nephrolithotomy Market Trends And Strategies

4. Percutaneous Nephrolithotomy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Percutaneous Nephrolithotomy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Percutaneous Nephrolithotomy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Percutaneous Nephrolithotomy Market Growth Rate Analysis
  • 5.4. Global Percutaneous Nephrolithotomy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Percutaneous Nephrolithotomy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Percutaneous Nephrolithotomy Total Addressable Market (TAM)

6. Percutaneous Nephrolithotomy Market Segmentation

  • 6.1. Global Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Magnesium Ammonium Phosphate Stone Type
  • Calcareous Type
  • Uric Acid Calculi Type
  • 6.2. Global Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Accessories
  • Devices
  • Services
  • 6.3. Global Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
  • 6.4. Global Percutaneous Nephrolithotomy Market, Sub-Segmentation Of Magnesium Ammonium Phosphate Stone Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Struvite Stones
  • Triple Phosphate Stones
  • 6.5. Global Percutaneous Nephrolithotomy Market, Sub-Segmentation Of Calcareous Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Calcium Oxalate Stones
  • Calcium Phosphate Stones
  • 6.6. Global Percutaneous Nephrolithotomy Market, Sub-Segmentation Of Uric Acid Calculi Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Uric Acid Stones
  • Secondary Uric Acid Stones

7. Percutaneous Nephrolithotomy Market Regional And Country Analysis

  • 7.1. Global Percutaneous Nephrolithotomy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Percutaneous Nephrolithotomy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Percutaneous Nephrolithotomy Market

  • 8.1. Asia-Pacific Percutaneous Nephrolithotomy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Percutaneous Nephrolithotomy Market

  • 9.1. China Percutaneous Nephrolithotomy Market Overview
  • 9.2. China Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Percutaneous Nephrolithotomy Market

  • 10.1. India Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Percutaneous Nephrolithotomy Market

  • 11.1. Japan Percutaneous Nephrolithotomy Market Overview
  • 11.2. Japan Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Percutaneous Nephrolithotomy Market

  • 12.1. Australia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Percutaneous Nephrolithotomy Market

  • 13.1. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Percutaneous Nephrolithotomy Market

  • 14.1. South Korea Percutaneous Nephrolithotomy Market Overview
  • 14.2. South Korea Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Percutaneous Nephrolithotomy Market

  • 15.1. Western Europe Percutaneous Nephrolithotomy Market Overview
  • 15.2. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Percutaneous Nephrolithotomy Market

  • 16.1. UK Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Percutaneous Nephrolithotomy Market

  • 17.1. Germany Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Percutaneous Nephrolithotomy Market

  • 18.1. France Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Percutaneous Nephrolithotomy Market

  • 19.1. Italy Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Percutaneous Nephrolithotomy Market

  • 20.1. Spain Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Percutaneous Nephrolithotomy Market

  • 21.1. Eastern Europe Percutaneous Nephrolithotomy Market Overview
  • 21.2. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Percutaneous Nephrolithotomy Market

  • 22.1. Russia Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Percutaneous Nephrolithotomy Market

  • 23.1. North America Percutaneous Nephrolithotomy Market Overview
  • 23.2. North America Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Percutaneous Nephrolithotomy Market

  • 24.1. USA Percutaneous Nephrolithotomy Market Overview
  • 24.2. USA Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Percutaneous Nephrolithotomy Market

  • 25.1. Canada Percutaneous Nephrolithotomy Market Overview
  • 25.2. Canada Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Percutaneous Nephrolithotomy Market

  • 26.1. South America Percutaneous Nephrolithotomy Market Overview
  • 26.2. South America Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Percutaneous Nephrolithotomy Market

  • 27.1. Brazil Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Percutaneous Nephrolithotomy Market

  • 28.1. Middle East Percutaneous Nephrolithotomy Market Overview
  • 28.2. Middle East Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Percutaneous Nephrolithotomy Market

  • 29.1. Africa Percutaneous Nephrolithotomy Market Overview
  • 29.2. Africa Percutaneous Nephrolithotomy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Percutaneous Nephrolithotomy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Percutaneous Nephrolithotomy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Percutaneous Nephrolithotomy Market Competitive Landscape And Company Profiles

  • 30.1. Percutaneous Nephrolithotomy Market Competitive Landscape
  • 30.2. Percutaneous Nephrolithotomy Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Coloplast Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Percutaneous Nephrolithotomy Market Other Major And Innovative Companies

  • 31.1. B. Braun
  • 31.2. Cook Medical
  • 31.3. Teleflex Incorporated
  • 31.4. Karl Storz Se And Co. KG
  • 31.5. Merit Medical Systems
  • 31.6. Richard Wolf GmbH
  • 31.7. AngioDynamics
  • 31.8. Argon Medical Devices
  • 31.9. Dornier MedTech
  • 31.10. EDAP TMS
  • 31.11. Allengers Medical Systems Limited
  • 31.12. DirexGroup
  • 31.13. Envaste Limited
  • 31.14. ELMED Lithotripsy Systems
  • 31.15. PolyDiagnost

32. Global Percutaneous Nephrolithotomy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Percutaneous Nephrolithotomy Market

34. Recent Developments In The Percutaneous Nephrolithotomy Market

35. Percutaneous Nephrolithotomy Market High Potential Countries, Segments and Strategies

  • 35.1 Percutaneous Nephrolithotomy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Percutaneous Nephrolithotomy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Percutaneous Nephrolithotomy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제